0 items USD 0.00Search
- Did you mean
- here+
Your search for "HER2+" gave back 7 results.
The global HER2 Antibodies market size was valued at US$ 8106.9 million in 2023. With growing demand in downstream market, the HER2 Antibodies is...
Catalog:
LPI
March 2024
Price: USD 3,660.00
HER2 is the target of the monoclonal antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
The global E-Prescribing market was valued at US$ 815 million in 2023 and is anticipated to reach US$ 2016.4 million by 2030, witnessing a CAGR of 13...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
E-prescribing or electronic prescribing is a process involving the electronic generation and sending of prescription orders for the convenience of...
Catalog:
MRRPB5
March 2024
Price: USD 3,950.00
Patuzumab is a monoclonal antibody. It was the first monoclonal antibody called an "HER dimerization inhibitor." By binding to HER2, it...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Trastuzumab, a monoclonal antibody against Her2, blocks the growth of cancer cells by attaching itself to Her2, preventing epidermal growth factor...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Targeted therapy is to design corresponding therapeutic drugs for the identified cancer-causing site (the site can be a protein molecule inside the...
Catalog:
MRRPB5
March 2024
Price: USD 3,950.00
